SCHEMBL128236

SCHEMBL128236

O=S(=O)(O)c1cccc(S(=O)(=O)O)c1.[NaH].[NaH]

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.67
HSD17B10 Q99714 4/20 0.67
TSHR P16473 3/20 0.67
TDP1 Q9NUW8 1/20 0.67
SMN1; SMN2 Q16637 2/20 0.62
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
NAPRT Q6XQN6 1/20 0.48
LMNA P02545 2/20 0.46
NT5E P21589 1/20 0.44
SNCA P37840 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
POLB P06746 1/20 0.41
CYP2D6 P10635 1/20 0.41
SENP3 Q9H4L4 2/20 0.41
SENP2 Q9HC62 2/20 0.41
SENP1 Q9P0U3 2/20 0.41
SUMO2 P61956 1/20 0.41
SUMO1 P63165 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29222010 1.00 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2
SCHEMBL151444 0.97 ALDH1A1 (0.70) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2
SCHEMBL1563586 0.97 ALDH1A1 (0.70) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2
SCHEMBL5343773 0.94 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2
Hydrochloric Acid SCHEMBL5873323 0.94 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2
SCHEMBL2785772 0.94 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2
SCHEMBL2289285 0.94 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2
Hydrochloric Acid SCHEMBL890392 0.94 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2
SCHEMBL9550121 0.94 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2
Water SCHEMBL10990733 0.94 ALDH1A1 (0.67) ALDH1A1HSD17B10TSHRTDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4136273-A1 METHOD AND COMPOSITION FOR ETCHING MOLYBDENUM Entegris, Inc. (US) 2023-02-22 EP claimed
WO-2021211708-A1 METHOD AND COMPOSITION FOR ETCHING MOLYBDENUM ENTEGRIS, INC. (US) 2021-10-21 WO claimed
CN-108285834-B Detergent composition 广州立白企业集团有限公司 2020-04-10 CN claimed
CN-110291185-A BLOOD SUGAR LEVEL MEASUREMENT CHIP AND BLOOD SUGAR LEVEL MEASUREMENT DEVICE SET 泰尔茂株式会社 2019-09-27 CN claimed
CN-1646677-A Detergent granule comprising nonionic surfactant and hydrotrope PROCTER & GAMBLE (US) 2005-07-27 CN claimed
US-20030195134-A1 Detergent granule comprising a nonionic surfactant and a hydrotrope THE PROCTER & GAMBLE COMPANY 2003-10-16 US claimed
EP-1352951-A1 Detergent granule comprising a nonionic surfactant and a hydrotrope The Procter & Gamble Company (US) 2003-10-15 EP claimed
US-5958368-A HYDROTHERMAL REACTION OF ALKYLTRIMETHYLAMMONIUM HALIDE AND WATER SOLUBLE ORGANIC SALTS; CALCINING RESULTING PRECIPITATE; RANDOMLY INTERCONNECTED CHANNELS OF UNIFORM DIAMETER ALLOW DIFFUSION OF REACTANTS; IMPROVED HYDROTHERMAL STABILITY YUKONG LIMITED (KR) 1999-09-28 US claimed
US-5942208-A STABILIZING THE HYDROTHERMAL REACTION OF ZEOLITE MCM-41 BY MIXING ALKYLTRIMETHYLAMMONIUM SURFACTANT; SUBJECTING TO HYDROTHERMAL REACTION; MIXING ORGANIC OR INORGANIC WATER-SOLUBLE SALTS; HYDROTHERMAL REACTION; CALCINING YU KONG LIMITED (KR) 1999-08-24 US claimed
EP-0661965-B1 HAIR CONDITIONING STYLE CONTROL SHAMPOO COLGATE PALMOLIVE CO (US) 1999-06-30 EP claimed
US-5500668-A INK JET PRINTING XEROX CORPORATION (US) 1996-03-19 US claimed
EP-0661965-A1 HAIR CONDITIONING STYLE CONTROL SHAMPOO Colgate-Palmolive Company (US) 1995-07-12 EP claimed
WO-1994006410-A1 HAIR CONDITIONING STYLE CONTROL SHAMPOO COLGATE-PALMOLIVE COMPANY (US) 1994-03-31 WO claimed
US-20240167922-A1 TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD KYOTO UNIVERSITY (JP) 2024-05-23 US disclosed
CN-118027957-A Method for manufacturing long afterglow photon glass by long afterglow molecular microsphere and ink-jet printing and application thereof 中山大学 2024-05-14 CN disclosed
EP-4306927-A1 TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD Kyoto University (JP) 2024-01-17 EP disclosed
US-4265908-A s-Phenenyltris(sulfonylimino)tri-benzene mono- and di-sulfonic acids and salts complement inhibitors AMERICAN CYANAMID COMPANY (US) 1981-05-05 US disclosed
US-4208346-A COMPLEMENT INHIBITORS AMERICAN CYANAMID COMPANY (US) 1980-06-17 US disclosed
US-4172089-A COMPLEMENT INHIBITOR TRI- OR HEXA-PHENYL ESTER INTERMEDIATES AMERICAN CYANAMID COMPANY (US) 1979-10-23 US disclosed
US-4117003-A COMPLEMENT INHIBITORS AMERICAN CYANAMID COMPANY (US) 1978-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240167922-A1 TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD TST, TTR, ALB ALDH1A1 3942/4885HSD17B10 2184/4885TSHR 2764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.